03/12/2020
Quinta e última parte de uma série sobre Microbiota.
Referências:
Debojyoti, D., & Abhishek, M. (2020). Gut microbiota and Covid-19–possible link and implications. Virus Res.
Hammer, J., Numa, A., & Newth, C. J. L. (1997). Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatric pulmonology, 23(3), 176-183.
He, Y., Wang, J., Li, F., & Shi, Y. (2020). Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections. Frontiers in Microbiology, 11, 1302.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Kalantar-Zadeh, K., Ward, S. A., Kalantar-Zadeh, K., & El-Omar, E. M. (2020). Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles. ACS nano.
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., ... & Osswald, S. (2020). SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?. European Heart Journal.
Tortora, G. J., Funke, B. R., & Case, C. L. (2012). Microbiologia. In Microbiologia (pp. 934-934).
Viana, S. D., Nunes, S., & Reis, F. (2020). ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities–Role of gut microbiota dysbiosis. Ageing research reviews, 101123.
Imagens de proteínas http://pdb101.rcsb.org/